new_0222_0505|FNCH|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|price_next_month|price_second_month
new_0222_0505|FNCH|1|Finch Therapeutics Group Inc Total Current Assets (Quarterly) (USD)|Finch Therapeutics Group Inc Cash and Short Term Investments (Quarterly) (USD)|Finch Therapeutics Group Inc Inventories (Quarterly) (USD)|Finch Therapeutics Group Inc Net PP&E (Quarterly) (USD)|Finch Therapeutics Group Inc Goodwill and Intangibles (Quarterly) (USD)|Finch Therapeutics Group Inc Total Liabilities (Quarterly) (USD)|Finch Therapeutics Group Inc Total Current Liabilities (Quarterly) (USD)|Finch Therapeutics Group Inc Total Long Term Liabilities (Quarterly) (USD)|Finch Therapeutics Group Inc Total Deposits (Quarterly) (USD)|Finch Therapeutics Group Inc Book Value (Quarterly) (USD)|Finch Therapeutics Group Inc Retained Earnings (Quarterly) (USD)|Finch Therapeutics Group Inc Treasury Stock (Quarterly) (USD)|Finch Therapeutics Group Inc EV to Revenues|Finch Therapeutics Group Inc EV to Earnings|Finch Therapeutics Group Inc EV to Free Cash Flow|Finch Therapeutics Group Inc EV to Assets (Quarterly)|Finch Therapeutics Group Inc PS Ratio|Finch Therapeutics Group Inc PE Ratio|Finch Therapeutics Group Inc Price to Book Value|Finch Therapeutics Group Inc PEG Ratio|Finch Therapeutics Group Inc Debt to Equity Ratio|Finch Therapeutics Group Inc Dividend Yield|Finch Therapeutics Group Inc Shareholder Yield (TTM)|Finch Therapeutics Group Inc Percent of Shares Outstanding Short|Finch Therapeutics Group Inc Total Receivables (Quarterly) (USD)|Finch Therapeutics Group Inc Total Payables (Quarterly) (USD)|Finch Therapeutics Group Inc Total Capital Stock (Quarterly) (USD)|Finch Therapeutics Group Inc Return on Invested Capital|Finch Therapeutics Group Inc Quality Ratio Score|Finch Therapeutics Group Inc Momentum Score|Finch Therapeutics Group Inc Beta (1Y)|Finch Therapeutics Group Inc Sustainable Growth Rate (TTM)|Finch Therapeutics Group Inc Institutional Investor Ownership Percentage|Finch Therapeutics Group Inc Average Diluted Shares Outstanding (Quarterly)|Finch Therapeutics Group Inc Total Employees (Annual)|Finch Therapeutics Group Inc EPS Diluted (Quarterly) (USD)|Finch Therapeutics Group Inc Shares Outstanding|Finch Therapeutics Group Inc Repurchase of Capital Stock (Quarterly) (USD)|Finch Therapeutics Group Inc Ordinary Shares Number (Quarterly)|Finch Therapeutics Group Inc Payout Ratio|Finch Therapeutics Group Inc Quick Ratio (Quarterly)|Finch Therapeutics Group Inc Normalized Diluted EPS (Quarterly) (USD)|Finch Therapeutics Group Inc Stock Buybacks (Quarterly) (USD)|Finch Therapeutics Group Inc Effective Tax Rate (TTM)|Finch Therapeutics Group Inc Return on Equity|Finch Therapeutics Group Inc Net Income (TTM) (USD)|Finch Therapeutics Group Inc Revenue (TTM) (USD)|Finch Therapeutics Group Inc Dividend Per Share (Quarterly) (USD)|Finch Therapeutics Group Inc Revenue (Quarterly) (USD)|Finch Therapeutics Group Inc Gross Profit (Quarterly) (USD)|Finch Therapeutics Group Inc SG&A Expense (Quarterly) (USD)|Finch Therapeutics Group Inc Pre-Tax Income (Quarterly) (USD)|Finch Therapeutics Group Inc Net Income (Quarterly) (USD)|Finch Therapeutics Group Inc Net Interest Income (Quarterly) (USD)|Finch Therapeutics Group Inc Price (USD)|Finch Therapeutics Group Inc Total Return Price (USD)|Finch Therapeutics Group Inc Enterprise Value (USD)|Finch Therapeutics Group Inc 30-Day Average Daily Volume|Finch Therapeutics Group Inc 1 Year Price Returns (Daily)||
new_0222_0505|FNCH|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric||
new_0222_0505|FNCH|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|quarterly||
new_0222_0505|FNCH|5|91|91|0|91|91|91|91|91|0|91|91|0|1.44396551724|91.5|1.44396551724|91.5|1.44396551724|0|1.44196428571|0|91|1.44396551724|91.5|15.3|91|91|91|92|0|0|0|92|30.6|91.3333333333|91|91.3333333333|29.125|0|91|91|91|91.3333333333|91.3333333333|91|92|91|91|0|91.3333333333|0|91.3333333333|91.3333333333|91.3333333333|91.3333333333|1.44396551724|1.44396551724|1.44396551724|1.44334975369|0||
new_0222_0505|FNCH|6|3|3|0|3|3|3|3|3|0|3|3|0|232|2|232|2|232|0|224|0|3|232|2|20|3|3|3|1|0|0|0|1|10|6|3|6|8|0|3|3|3|6|6|3|1|3|3|0|6|0|6|6|6|6|232|232|232|203|0||
new_0222_0505|FNCH|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily||
new_0222_0505|FNCH|202003||||||||||||||||||||||||||||||||||34.692||-6.8324||||||-0.2277|0||||||1.792||2.258|-7.901|-7.901|0.091|||||||
new_0222_0505|FNCH|202006||||||||||||||||||||||||||||||||||34.692||-7.142||||||-0.2381|0||||||2.349||2.574|-8.259|-8.259|0.021|||||||
new_0222_0505|FNCH|202009||||||||||||||||||||||||||||||||||34.692||-8.7254||||||-0.2908|0||||||1.771||2.807|-10.09|-10.09|-0.007|||||||
new_0222_0505|FNCH|202012|106.164|99.71||7.004|50.957|261.056|11.486|249.57||-95.718|-102.835||||||||||-0.0189||||1.095|2.887|0.008|||||||45.8954|131|-8.5571|||45.8954|0|8.7763|-0.285||0||-39.341|7.719||1.807||6.372|-13.091|-13.091|0.001|||||||
new_0222_0505|FNCH|202103|198.341|193.023||16.437|50.957|26.494|11.503|14.991||239.457|-116.816||60.2854|-12.5824|-10.9975|2.1489|77.7154||3.1851||0.0076|0|-15.5819|0.982|2.303|4.198|0.047||||||18.6891|14.0333|165|-30|1.5742||47.2273|0|16.9804|-1|-118.575|0||-45.421|9.48||3.553||4.552|-13.981|-13.981|-0.001|480|480|656.418|233691.9333||408.6|412.8
new_0222_0505|FNCH|202106|177.003|168.136||18.327|50.957|22.135|9.524|12.611||228.193|-131.985||50.1099|-9.5382|-7.1132|1.994|46.5484||2.9243||0|0|-17.7699|0.7078|2.25|1.727|0.047|-41.8037||||-42.2101|14.4807|47.3799|186|-9.6|1.5809||47.4258|0|17.8902|-0.3586|0|0|-42.2101|-52.331|9.961||2.83||5.882|-15.169|-15.169|0.007|409.5|409.5|456.0817|84841.3667||398.7|424.5
new_0222_0505|FNCH|202109|156.167|149.2||19.546|50.957|13.178|8.851|4.327||219.801|-141.94||23.9449|-8.9607|-5.8644|2.0075|48.6117||2.7655||0|0|-19.2206|0.5022|2.399|1.382|0.047|-35.0692||||-35.2835|19.1504|47.4452|191|-6.3|1.5818||47.455|0|17.1279|-0.21|0|0|-35.2835|-52.196|19.533||11.343||5.739|-9.955|-9.955|0.008|409.2|409.2|479.0547|34010.5||394.8|498.6
new_0222_0505|FNCH|202112||133.481||||23.145|||||||16.5956||-4.0645||19.7869||2.1773|||0||0.5348|||||||||20.3767|||-12|1.5837||||||-0.001|||-58.16|18.532||0.806||5.065||-19.055||299.7|299.7|325.1052|170480.9667||256.8|260.7
new_0222_0505|FNCH|202203||106.931||||24.842|||||||||||10.8898||1.1799|||||||||||||||||-15.6|1.5844|||||||||-68.746|15.333||0.354||9.404||-24.567||154.8|154.8|111.7841|33053.4667||74.1|71.1
new_0222_0505|FNCH|202206||104.673||||69.209|||||||||||8.6093||0.7089||0.0919|||||||||||||||-14.31|1.5895|||||||||-76.277|12.864||0.361||8.164||-22.7||83.4|83.4|25.283|153608.8||59.7|75
new_0222_0505|FNCH|202209||85.292||||67.102|||||||||||6.2448||0.4946||0.1211|||||||||||||||-25.38|1.5942|||||||||-106.693|1.659||0.138||9.584||-40.371||50.7|50.7|-9.4603|51729.7667||45.6|25.8
new_0222_0505|FNCH|202212||71.038||||67.228|||||||||||10.4736||0.1486||0.1531|||||||||||||||-16.8|1.6018|||||||||-114.646|0.861||0.008||9.04||-27.008||10.95|10.95|-47.665|102171.1667||15|12.42
new_0222_0505|FNCH|202303||41.684||||46.088|||||||||||19.3853||0.171|||||||||||||||||-39.19|1.6048|||||||||-152.426|0.614||0.107||9.617||-62.347||10.5|10.5|-22.7634|134430.9667||13.239|8.64
new_0222_0505|FNCH|202306||34.051||||38.963|||||||||||20.4861||0.4003|||||||||||||||||-4.33|1.6048|||||||||-136.676|||||8.877||-6.95||7.89|7.89|-29.0221|153916.5667||8.9|6.4405
new_0222_0505|FNCH|202309||28.779||||33.68|||||||||||14.2706||0.3153|||||||||||||||||-1.51|1.605|||||||||-98.721|||||3.735||-2.416||5.48|5.48|-25.2567|9750.9333||3.935|3.84
new_0222_0505|FNCH|202312||25.124||||32.487|||||||||||9.2388||0.2202|||||||||||||||||-1.89|1.6058|||||||||-74.754|||||4.681||-3.041||3.54|3.54|-23.0945|38719.2333||2.75|2.605
new_0222_0505|FNCH|202403||20.762||||31.054|||||||||||7.5631||0.2031|||||||||||||||||-2.41|1.6058|||||||||-16.283|||||5.164||-3.876||2.8941|2.8941|-20.4767|24324.6333||2.3|0.8801
new_0222_0505|FNCH|202406||16.035||||31.357|||||||||||3.5034||0.113|||||||||||||||||-3.01|1.6058|||||||||-14.167|||||6.109||-4.834||1.34|1.34|-18.6102|46923.5333||1.86|12.81
new_0222_0505|FNCH|202409|||||||||||||||||30.0708||1.2987||||||||||||||||||||||||||||||||||||11.5|11.5|2.4317|4557.8||11.95|12
new_0222_0505|FNCH|202412|||||||||||||||||28.4235||1.2276||||||||||||||||||||||||||||||||||||10.87|10.87|1.42|2721.5667||11.2518|15.79
new_0222_0505|FNCH|202503|||||||||||||||||36.7565||1.5875||||||||||||||||||||||||||||||||||||14.0568|14.0568|6.5374|1981.1667||12.3|13.7
new_0222_0505|FNCH|202506|||||||||||||||||33.9931||1.4681||||||||||||||||||||||||||||||||||||13|13|4.8404|1533.1||13.075|